Pharmaceutical Technology

OCTOBER 20, 2022

PIC Therapeutics has raised $35m in a Series A funding round led by OrbiMed to develop therapies for drug-resistant breast cancer. The funding round saw participation from current investors of the company, Advent Life Sciences and Belinda Termeer. This drug is an allosteric protein translation modulator that acts on eIF4E.

Development 130

Development Drugs Protein Life Science 130

Drug Discovery World

FEBRUARY 23, 2023

This is episode four, How machine learning and lab automation are changing the future of protein therapeutics. The post Podcast: ML and lab automation are changing protein therapeutics appeared first on Drug Discovery World (DDW). Only one entry per person. Selfie must include supplement front cover to qualify.

Protein 52

Protein Life Science Development Drugs 52

Drug Discovery World

MARCH 22, 2024

The site will provide Recursion and Valence Labs, the company’s artificial intelligence (AI) research engine, with access to European talent and a life science ecosystem from which to work. Professor Bronstein works in geometric deep learning, graph neural networks, and protein design.

Life Science 64

Life Science Drugs Engineer Protein 64

pharmaphorum

NOVEMBER 7, 2022

1910 Genetics, a biotechnology company integrating artificial intelligence (AI), computation and biological automation to accelerate the design of small molecule and protein therapeutics, has appointed Patrick Genestin as chief business officer. .” Patrick Genestin, 1910 Genetics . ” Kristen Harrington-Smith, ADC Therapeutics .

Life Science 105

Life Science Genetics Business Development Marketing 105

XTalks

MARCH 31, 2023

By growing high quality crystal structures of protein-based therapeutics under microgravity, researchers can gain better insights into their complex structures and stability. This can help guide better drug formulations, delivery of higher therapeutic doses and improved biomanufacturing processes.

Protein 97

Protein Research Development Manufacturing 97

Drug Discovery World

DECEMBER 12, 2022

GenScript Biotech, a provider of life-science research tools and services, is partnering with Allozymes, a Singapore-based biotech startup, with aims to accelerate the enzyme discovery and development process. .

Protein 52

Protein Life Science Engineer Production 52

XTalks

JANUARY 5, 2021

Both drug discovery and drug repurposing to manage and treat the disease will also continue as experts learn more about the virology and epidemiology of the novel SARS-CoV-2 coronavirus that wreaked havoc in 2020. These include monoclonal antibody drugs, which are attractive therapeutic agents owing to their targeted specificity.

Life Science 98

Life Science Clinical Trials Clinical Trials Trials 98

XTalks

DECEMBER 17, 2021

Xtalks is taking a look at some of the major stories and innovations of the year in the life sciences, many of which were driven by new, emerging and improved technologies. The year 2021 was all about continuing innovations in the life sciences. Life Science Innovations: Malaria and Influenza Vaccines.

Life Science 98

Life Science Vaccination Vaccine Trials 98

Drug Discovery World

FEBRUARY 23, 2023

This is episode four, How machine learning and lab automation are changing the future of protein therapeutics. The post DDW Events podcast: How machine learning and lab automation are changing the future of protein therapeutics appeared first on Drug Discovery World (DDW). Selfie must include supplement front cover to qualify.

Protein 52

Protein Life Science Development Drugs 52

Drug Discovery World

FEBRUARY 23, 2023

Kristen Hopson , Vice President of Preclinical Discovery and Development at Generate Biomedicines, and Yup Liu , Associate Director, HTS at Generate Biomedicines, reflect on the impact of AI, ML cloud computing, and advances in laboratory automation and high-throughput screening (HTS) on life science research.

Protein 52

Protein Life Science Bioassay Development 52

Drug Discovery World

FEBRUARY 20, 2024

The drug discovery informatics market is predicted to grow from $3.77 The new report says the anticipated growth to 2028 will be fuelled by the expansion of precision medicine, advancements in drug-drug interaction prediction, analysis of patient-derived data, development of biosimilars, and the increasing number of drug candidates.

Marketing 52

Marketing Drugs Life Science Genome 52

BioPharma Reporter

MARCH 22, 2022

Fujifilm Irvine Scientific, Inc, has announced the acquisition of Shenandoah Biotechnology, a company supplying recombinant proteins to the drug discovery, life science research, and cell and gene therapy markets.

Gene Therapy 98

Gene Therapy Life Science Protein Gene 98

Drug Discovery World

DECEMBER 14, 2023

With leading academic institutions and significant recent investment, Glasgow is shaping up to be an important centre for drug discovery and development in the UK. A centre of excellence for cancer research The announcement of the new Health Innovation Hub follows other examples of significant investment in Glasgow life sciences.

Drugs 75

Drugs Life Science Research Scientist 75

Drug Discovery World

OCTOBER 26, 2023

The technologies cover the whole range of biomolecules from genes to protein to metabolites. As one key element for PanOmics-driven drug discovery we have established leading high-throughput and high-resolution transcriptomics data generation capabilities.

Drugs 52

Drugs Protein Genome Genomics 52

XTalks

JULY 19, 2022

The US Food and Drug Administration (FDA) has given emergency use authorization (EUA) to Novavax’s COVID-19 vaccine, making it the fourth authorized vaccine in the US against COVID-19. Nevertheless, 77 percent of those polled said that even if a protein-based COVID shot were authorized in the US, they still would not get it.

Vaccination 94

Vaccination Vaccine Protein Clinical Trials 94

Drug Discovery World

MAY 25, 2023

Several new products for the life sciences sector have been launched over the last month, from miniature semiconductor chip (MSC) technology to a new inhalation testing service. The post The latest drug discovery product launches appeared first on Drug Discovery World (DDW). DDW provides an update.

Production 52

Production Reagent DNA Drugs 52

XTalks

JUNE 20, 2022

Alnylam Pharmaceuticals, a leading RNA interference (RNAi) therapeutics biopharmaceutical company, announced it received approval from the US Food and Drug Administration (FDA) for its RNAi therapeutic Amvuttra (vutrisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated (ATTR) amyloidosis in adults.

FDA Approval 98

FDA Approval Protein Genetics RNA 98

Drug Discovery World

OCTOBER 16, 2023

The United Kingdom has established itself as a hub for drug discovery expertise worldwide. There is a range of reasons why this area has become focal point for drug discovery, one of which is the fact that it encompasses the University of Oxford and the University of Cambridge, two of the oldest and most prestigious universities in the world.

Drugs 75

Drugs Life Science Gene Therapy Genome 75

pharmaphorum

JANUARY 11, 2023

A slow journey to drug discovery. Asked about the impetus behind Verseon’s work in the sector, Prakash explained that he began the company “to change the way the world finds new drugs”. Today’s pharmaceutical drug discovery process essentially relies on trial and error,” he expanded. “To Not an unambitious goal.

Big Data 122

Big Data Drugs Clinical Trials Clinical Trials 122

Drug Discovery World

APRIL 27, 2023

The report notes that the focus on science and pharma throughout the Covid-19 pandemic has resulted in the emergence of new locations as life science hubs and name checks Boston, Massachusetts and San Francisco, California as examples of centres with heightened investment appeal in the life sciences 1.

Life Science 52

Life Science Drugs Research Gene Splicing 52

XTalks

MAY 7, 2021

As Novavax awaits emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for its protein-based COVID-19 vaccine NVX-CoV2373, the company shared new data this week on the vaccine’s efficacy against the South African B.1.351 1.351 variant.

Protein 97

Protein Vaccination Vaccine Trials 97

Drug Discovery World

OCTOBER 12, 2023

BioMap has entered a strategic collaboration with Sanofi to co-develop AI modules for biotherapeutic drug discovery, leveraging BioMap’s AI platform. However, in life science, labeled data are often in short supply. Traditional AI methods require vast amounts of labeled data to make accurate predictions.

Development 52

Development Protein Life Science Pharma Companies 52

Drug Discovery World

JANUARY 9, 2024

Thirteen new-to-market therapeutics and drugs poised to launch in 2024 will achieve ‘blockbuster’ status by 2029 or deliver game-changing benefits to patients. The 2024 Drugs to Watch, are: 1. Due to a delayed US launch it remains a drug to watch for 2024.

Drugs 69

Drugs Antibody Gene Editing Medicine 69

Drug Discovery World

APRIL 11, 2023

Here, we take a look at the latest drug discovery efforts to meet this unmet need. The molecule, known as lissodendoric acid A, appears to counteract other molecules that can damage DNA, RNA and proteins and even destroy whole cells.

Research 52

Research Drugs Life Science RNA 52

Pharmaceutical Technology

MARCH 1, 2023

According to GlobalData, Phase I drugs for Neuroendocrine Tumors have a 74% phase transition success rate (PTSR) indication benchmark for progressing into Phase II. GlobalData’s report assesses how Nedisertib’s drug-specific PTSR and Likelihood of Approval (LoA) scores compare to the indication benchmarks.

Gene Editing 100

Gene Editing DNA Cosmetics Life Science 100

Pharmaceutical Technology

MARCH 1, 2023

According to GlobalData, Phase I drugs for Head And Neck Cancer Squamous Cell Carcinoma have an 80% phase transition success rate (PTSR) indication benchmark for progressing into Phase II. GlobalData’s report assesses how Nedisertib’s drug-specific PTSR and Likelihood of Approval (LoA) scores compare to the indication benchmarks.

Gene Editing 100

Gene Editing DNA Cosmetics Life Science 100

Drug Discovery World

OCTOBER 20, 2023

The latest acquisitions and strategic partnerships in the drug discovery and development sector reveal the areas where companies predict significant growth in the near future: proteomics, CAR-T, antibody discovery, artificial intelligence (AI) and microbiomics. We aim to continue to ‘open up’ the druggable antibody space.”

Drugs 52

Drugs Antibody DNA Gene Therapy 52

Drug Discovery World

MARCH 14, 2023

Teitur Trophics, a biotech company developing new treatments for patients suffering from neurodegenerative diseases, has complete a €28M Series A financing. The financing was co-led by Sunstone Life Science Ventures and Sound Bioventures, with participation from new investors, Industrifonden, Innovestor’s Life Science Fund and P53 Invest.

Life Science 52

Life Science Clinical Development Development Drugs 52

XTalks

NOVEMBER 23, 2021

The reliance of COVID-19 vaccine manufacturing on only a handful of countries globally has made many nations realize the need for large-scale, domestic biomanufacturing facilities for drugs and vaccines as preparation for potential disease outbreaks and health emergencies in the future.

Manufacturing 98

Manufacturing Vaccination Vaccine Drugs 98

XTalks

MAY 2, 2024

In 2023, the US Food and Drug Administration (FDA) approved a record-breaking 61 drugs, the most in history. Since January, the FDA has already signed off on more than a dozen novel drugs. The agency is reviewing applications for several highly anticipated drugs for approval in 2024.

Drugs 52

Drugs FDA Approval Sales Vaccination 52

Drug Discovery World

MAY 13, 2024

MA: Regarding vaccine development specifically, and the role my team plays in the development of cryogenic electron microscopy (cryo-EM) technology, we see the study and dissemination of virus structures, and the proteins that comprise them, as vital to vaccine design. For example, there are global monitoring efforts for new Covid strains.

Vaccination 59

Vaccination Vaccine Protein Antibody 59

Drug Discovery World

OCTOBER 6, 2022

As we start to look beyond the pandemic, which areas of Europe’s drug discovery community should we take note of? The European drug discovery sector is buoyant. With key players including AstraZeneca, Bayer, Novartis and Pfizer pushing the boundaries of drug development, the reason behind this growth is evident. Valued at $14.8

Development 52

Development Drugs Life Science Marketing 52

Drug Discovery World

FEBRUARY 25, 2023

The post Don’t miss the DDW Events podcast series for SLAS2023 appeared first on Drug Discovery World (DDW). To win, simply make your way to the SLAS Booth at 2621, pick up a copy of the official SLAS supplement published by DDW, and take a selfie with it. Selfie must include supplement front cover to qualify.

Life Science 52

Life Science Protein Drugs 52

Drug Discovery World

OCTOBER 20, 2022

DDW Multimedia Editor Megan Thomas takes a broad look at the drug discovery and development landscape in Japan and highlights how it is bolstered by government policies, investment, collaboration, start-up ecosystems and academic research. . Similarly, biosimilars are expected to grow. Government policies . Investment and collaboration .

Development 52

Development Drugs Life Science Marketing 52

Drug Discovery World

JULY 11, 2023

Tim Lowery , President, JSR Life Sciences, asks whether artificial intelligence can do for life sciences what it has done in other sectors and whether these tools can keep up with the complexities of human biology. So, where do we go from here to realise their potential in life sciences?

Big Data 40

Big Data Development Life Science Drugs 40

Drug Discovery World

NOVEMBER 27, 2023

By Anis H Khimani , PhD, Senior Strategy Leader, Life Sciences strategy group, Revvity, Inc. Across the biotherapeutics workflow The landscape of large molecule drug development has evolved significantly in recent decades. Stable clonal cell banks are used for GMP production of the final drug product.

Production 59

Production Engineer Gene Editing Gene 59

XTalks

MAY 24, 2022

Antiretroviral drugs for HIV are classified as integrase strand transfer inhibitors (INSTIs), nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), cytochrome P4503A (CYP3A) inhibitors, protease inhibitors (PIs) and others. Lenacapavir: A Treatment Candidate for HIV.

Drugs 98

Drugs Clinical Trials Clinical Trials Trials 98